ask="46.60"
ask_size="100"
average_daily_volume="1099490"
bid="37.50"
bid_size="100"
book_value="3.62"
change="+0.90"
change_from_200_day_moving_average="-2.07"
change_from_50_day_moving_average="2.14"
change_from_52_week_high="-11.10"
change_From_52_week_low="11.87"
change_in_percent="+2.09%"
close="44.05"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-145.92M"
eps_estimate_current_year="-2.25"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.30"
ex_dividend_date="N/A"
float_shares="85906000"
high="44.12"
high_52_weeks="55.15"
last_trade_date="2/17/2017"
last_trade_price="44.05"
last_trade_size="43282"
last_trade_time="4:00pm"
low="42.47"
low_52_weeks="32.18"
market_capitalization="3.84B"
moving_average_200_day="46.12"
moving_average_50_day="41.91"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.67"
open="42.90"
pe_ratio="N/A"
peg_ratio="0.54"
percent_change_from_200_day_moving_average="-4.48%"
percent_change_from_50_day_moving_average="+5.11%"
percent_change_from_52_week_high="-20.13%"
percent_change_from_52_week_low="+36.89%"
previous_close="43.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.91"
price_per_sales="250.60"
revenue="15.00M"
shares_outstanding="87114000"
short_ratio="3.01"
stock_exchange="NMS"
symbol="NBIX"
volume="617977"
weeks_range_52="32.18 - 55.15"
